PMC:7283670 / 124902-125251 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T91","span":{"begin":62,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A91","pred":"fma_id","subj":"T91","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T680","span":{"begin":301,"end":305},"obj":"Disease"}],"attributes":[{"id":"A680","pred":"mondo_id","subj":"T680","obj":"http://purl.obolibrary.org/obo/MONDO_0009358"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T171","span":{"begin":28,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T59361","span":{"begin":129,"end":142},"obj":"Chemical"},{"id":"T14291","span":{"begin":148,"end":158},"obj":"Chemical"},{"id":"T30090","span":{"begin":183,"end":194},"obj":"Chemical"},{"id":"T82055","span":{"begin":196,"end":205},"obj":"Chemical"},{"id":"T3319","span":{"begin":210,"end":221},"obj":"Chemical"},{"id":"T23937","span":{"begin":227,"end":236},"obj":"Chemical"},{"id":"T29147","span":{"begin":251,"end":260},"obj":"Chemical"}],"attributes":[{"id":"A59511","pred":"chebi_id","subj":"T59361","obj":"http://purl.obolibrary.org/obo/CHEBI_36807"},{"id":"A39832","pred":"chebi_id","subj":"T14291","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A94366","pred":"chebi_id","subj":"T30090","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A83971","pred":"chebi_id","subj":"T82055","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A25158","pred":"chebi_id","subj":"T3319","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A57916","pred":"chebi_id","subj":"T23937","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A78394","pred":"chebi_id","subj":"T29147","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T1037","span":{"begin":0,"end":349},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2564","span":{"begin":289,"end":292},"obj":"Gene"},{"id":"2565","span":{"begin":307,"end":315},"obj":"Species"},{"id":"2566","span":{"begin":50,"end":60},"obj":"Chemical"},{"id":"2567","span":{"begin":121,"end":142},"obj":"Chemical"},{"id":"2568","span":{"begin":172,"end":178},"obj":"Chemical"},{"id":"2569","span":{"begin":183,"end":194},"obj":"Chemical"},{"id":"2570","span":{"begin":196,"end":205},"obj":"Chemical"},{"id":"2571","span":{"begin":210,"end":221},"obj":"Chemical"},{"id":"2572","span":{"begin":227,"end":236},"obj":"Chemical"},{"id":"2573","span":{"begin":251,"end":260},"obj":"Chemical"}],"attributes":[{"id":"A2564","pred":"tao:has_database_id","subj":"2564","obj":"Gene:386757"},{"id":"A2565","pred":"tao:has_database_id","subj":"2565","obj":"Tax:2697049"},{"id":"A2566","pred":"tao:has_database_id","subj":"2566","obj":"MESH:C000606551"},{"id":"A2569","pred":"tao:has_database_id","subj":"2569","obj":"MESH:D053139"},{"id":"A2570","pred":"tao:has_database_id","subj":"2570","obj":"MESH:D019438"},{"id":"A2571","pred":"tao:has_database_id","subj":"2571","obj":"MESH:D053139"},{"id":"A2572","pred":"tao:has_database_id","subj":"2572","obj":"MESH:D061466"},{"id":"A2573","pred":"tao:has_database_id","subj":"2573","obj":"MESH:D019438"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These trials have specially focused on potency of Remdesivir, immunoglobulins, and combinational therapies, for example, Arbidol hydrochloride with interferon atomization, ASC09F and oseltamivir, ritonavir and oseltamivir, and lopinavir combined with ritonavir (https://clinicaltrials.gov/ct2/results?cond=\u00262019nCoV\u0026term=\u0026cntry=\u0026state=\u0026city=\u0026dist=)."}